Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AIM ImmunoTech Begins Dosing for Intranasal Ampligen Clinical Study

americanpharmaceuticalreviewMarch 15, 2021

Tag: aim , Ampligen , COVID-19

PharmaSources Customer Service